Berdel WE - Search Results

1

High-throughput analysis of genome-wide receptor tyrosine kinase expression in human cancers identifies potential novel drug targets.

Müller-Tidow C, Schwäble J, Steffen B, Tidow N, Brandt B, Becker K, Schulze-Bahr E, Halfter H, Vogt U, Metzger R, Schneider PM, Büchner T, Brandts C, Berdel WE, Serve H. Müller-Tidow C, et al. Among authors: berdel we. Clin Cancer Res. 2004 Feb 15;10(4):1241-9. doi: 10.1158/1078-0432.ccr-0954-03. Clin Cancer Res. 2004. PMID: 14977821

2

Fatigue as an important aspect of quality of life in patients with acute myeloid leukemia.

Schumacher A, Wewers D, Heinecke A, Sauerland C, Koch OM, van de Loo J, Büchner T, Berdel WE. Schumacher A, et al. Among authors: berdel we. Leuk Res. 2002 Apr;26(4):355-62. doi: 10.1016/s0145-2126(01)00145-x. Leuk Res. 2002. PMID: 11839378

3

Novel der(1)t(1;19) in two patients with myeloid neoplasias.

Tchinda J, Volpert S, Neumann T, Kennerknecht I, Ritter J, Büchner T, Berdel WE, Horst J. Tchinda J, et al. Among authors: berdel we. Cancer Genet Cytogenet. 2002 Feb;133(1):61-5. doi: 10.1016/s0165-4608(01)00505-2. Cancer Genet Cytogenet. 2002. PMID: 11890991

4

Carboplatin/etoposide induces remission of metastasised malignant peripheral nerve tumours (malignant schwannoma) refractory to first-line therapy.

Steins MB, Serve H, Zühlsdorf M, Senninger N, Semik M, Berdel WE. Steins MB, et al. Among authors: berdel we. Oncol Rep. 2002 May-Jun;9(3):627-30. Oncol Rep. 2002. PMID: 11956640

5

The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.

Linggi B, Müller-Tidow C, van de Locht L, Hu M, Nip J, Serve H, Berdel WE, van der Reijden B, Quelle DE, Rowley JD, Cleveland J, Jansen JH, Pandolfi PP, Hiebert SW. Linggi B, et al. Among authors: berdel we. Nat Med. 2002 Jul;8(7):743-50. doi: 10.1038/nm726. Epub 2002 Jun 24. Nat Med. 2002. PMID: 12091906

6

Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.

Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Böhmer FD, Müller-Tidow C, Berdel WE, Serve H. Mizuki M, et al. Among authors: berdel we. Blood. 2003 Apr 15;101(8):3164-73. doi: 10.1182/blood-2002-06-1677. Epub 2002 Dec 5. Blood. 2003. PMID: 12468433 Free article.

7

Cyclin A1 is highly expressed in aggressive testicular germ cell tumors.

Müller-Tidow C, Diederichs S, Schrader MG, Vogt U, Miller K, Berdel WE, Serve H. Müller-Tidow C, et al. Among authors: berdel we. Cancer Lett. 2003 Feb 10;190(1):89-95. doi: 10.1016/s0304-3835(02)00582-7. Cancer Lett. 2003. PMID: 12536081

8

Successive increases in human cyclin A1 promoter activity during spermatogenesis in transgenic mice.

Müller-Tidow C, Readhead C, Cohen AH, Asotra K, Idos G, Diederichs S, Cauvet T, Yang R, Berdel WE, Serve H, Koeffler HP. Müller-Tidow C, et al. Among authors: berdel we. Int J Mol Med. 2003 Mar;11(3):311-5. Int J Mol Med. 2003. PMID: 12579332

9

Phase I study of liposomal daunorubicin in relapsed and refractory acute myeloid leukemia.

Bieker R, Lerchenmüller C, Wehmeyer J, Serve HL, Mesters RM, Büchner T, Berdel WE. Bieker R, et al. Among authors: berdel we. Oncol Rep. 2003 Jul-Aug;10(4):915-20. Oncol Rep. 2003. PMID: 12792745 Clinical Trial.

10

Synergistic growth inhibitory effects of interferon-alpha and lovastatin on bcr-abl positive leukemic cells.

Müller-Tidow C, Kiehl M, Sindermann JR, Probst M, Banger N, Zühlsdorf M, Chou TC, Berdel WE, Serve H, Koch OM. Müller-Tidow C, et al. Among authors: berdel we. Int J Oncol. 2003 Jul;23(1):151-8. Int J Oncol. 2003. PMID: 12792788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

629 results

Search Page

Filters